• Profile
Close

Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II–III colorectal cancer patients

Cancer Management and Research Jul 27, 2018

Sun F, et al. - The predictive value of preoperative albumin-to-fibrinogen ratio (AFR), fibrinogen-to-pre-albumin ratio (FPR), fibrinogen (Fib), albumin (Alb), and pre-albumin (pre-Alb) in patients with colorectal cancer (CRC) was examined. For this analysis, 3 years of follow-up was conducted with 702 stage I–III resected CRC subjects diagnosed between January 2008 and December 2013. By X-tile software, Kaplan–Meier curve, and Cox regression model, optimal cutoff points and prognostic values of AFR, FPR, Fib, Alb, pre-Alb, and a novel carcinoembryonic antigen (CEA)-carbohydrate antigen 19-9 (CA199)-FPR (CCF) score were evaluated. The findings from the present study suggested that FPR, as well as CCF score, were promising biomarkers to predict the prognosis of CRC and to classify which stage II–III patients could benefit from adjuvant chemotherapy.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay